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ABSTRACT
Background: Data regarding the effects of tea, coffee, and milk on the risk of colorectal cancer are inconsistent. We
investigated associations of tea, coffee, and milk consumption with colorectal cancer risk and attempted to determine
if these exposures were differentially associated with the risks of proximal colon, distal colon, and rectal cancers.
Methods: Data from 854 incident cases and 948 controls were analyzed in a case-control study of colorectal cancer
in Western Australia during 2005–07. Multivariable logistic regression was used to analyze the associations of black
tea (with and without milk), green tea, herbal tea, hot coffee, iced coffee, and milk with colorectal cancer.
Results: Consumption of 1 or more cups of herbal tea per week was associated with a significantly decreased risk of
distal colon cancer (adjusted odds ratio, 0.37; 95% CI, 0.16–0.82; PTrend = 0.044), and consumption of 1 or more cups
of iced coffee per week was associated with increased risk of rectal cancer (adjusted odds ratio, 1.52; 95% CI,
0.91–2.54; PTrend = 0.004). Neither herbal tea nor iced coffee was associated with the risk of proximal colon cancer.
Hot coffee was associated with a possible increased risk of distal colon cancer. Black tea (with or without milk),
green tea, decaffeinated coffee, and milk were not significantly associated with colorectal cancer risk.
Conclusions: Consumption of herbal tea was associated with reduced risk of distal colon cancer, and consumption
of iced coffee was associated with increased rectal cancer risk.
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INTRODUCTION
Poor diet is a known modifiable risk factor for colorectal
cancer (CRC),1–4 and many foods and beverages have been
associated with increased or decreased risk of CRC.5 These
beverages include tea, coffee, and milk, which are among the
most commonly consumed beverages in the world.
Tea leaves are a source of flavonoid antioxidants—a
polyphenol subgroup.6,7 The polyphenol concentration is
highest in green tea.8,9 Previous reviews have shown that
polyphenols inhibit tumor invasion, cell proliferation, and
cell transformation, and induce tumor apoptosis.7,10 However,
observations from epidemiologic studies are inconsistent
regarding the role of black and green teas as risk factors for
CRC.11–13 Herbal tea, ie, any infusion made solely from herbs,
flowers, or other material of organic origin that does not
contain leaves from the tea bush, is also high in polyphenol
antioxidants.14 Although 2 case-control studies found an
inverse association between herbal tea and breast cancer
risk,15,16 to our knowledge the effect of herbal tea on CRC risk
has not been investigated.
Coffee has an antioxidant capacity up to 8 times that of an
equal volume of tea, depending on the preparation method
used.17 Unfiltered coffee also contains 2 important diter-
penes—cafestol and kahweol—which may reduce cancer risk
by altering the way the body metabolizes carcinogens.18–20
Conversely, coffee may function as a carcinogen by raising
plasma homocysteine levels21 or by increasing hydrogen
peroxide, a reactive oxygen species released during
roasting.22 A systematic review of prospective cohort studies
on coffee consumption and the risk of CRC concluded that the
evidence was inconclusive for an effect of coffee consumption
on CRC risk,23 although some case-control studies found
coffee to be protective in colon cancer but not rectal cancer.11
Milk and other dairy products have been hypothesized to
reduce the risk of CRC through their high calcium content.
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Calcium is thought to protect against CRC via several
biological mechanisms, including reduced cellular prolifer-
ation and promotion of cellular differentiation.24 Although
increased milk consumption might reduce CRC risk, the
evidence is not convincing.5
Data regarding the effects of tea, coffee, and milk on CRC
risk are inconsistent. This inconsistency may be partially due
to failure to distinguish among CRC subsites. Prior work
suggests that there are epidemiologic and etiologic differences
between colon and rectal cancers,25 as well as epidemiologic
and etiologic differences between cancer arising in the
proximal colon and in the distal colon.26 Few previous
studies of CRC have distinguished among the different origin
sites of cancers in the colorectum, even though tumors in
the proximal and distal colon develop along different
pathways26,27 and the effects of some risk factors vary by
subsite within the colorectum.26,28 We investigated the
associations of tea, coffee, and milk consumption with CRC
risk and attempted to determine if these exposures were
differentially associated with the risks of proximal colon,
distal colon, and rectal cancer.
METHODS
The Western Australian Bowel Health Study (WABOHS) was
a population-based case-control study of CRC.29,30 The cases
were histologically confirmed incident cases of CRC, aged 40
to 79 years, that were reported to the Western Australian
Cancer Registry between June 1, 2005 and August 31, 2007.
Controls had no previous diagnosis of CRC and were
randomly selected from the electoral roll by age (5-year age
group) and sex strata, based upon the distribution of CRC
cases in Western Australia in 2002. In total, 1544 eligible
cases were invited to participate and 918 agreed (59.5%).
Of the 2198 eligible controls invited, 1021 (46.5%) agreed to
participate.
Information on tumor site was obtained for each case from
the pathology report stored at the Western Australian Cancer
Registry. Tumors arising in the cecum, ascending colon,
hepatic flexure, and transverse colon were classified as
proximal colon cancers; tumors arising in the splenic
flexure, descending colon, and sigmoid colon were classified
as distal colon cancers; and tumors arising in the rectosigmoid
junction and rectum were classified as rectal cancers. Ethics
approval for the WABOHS was obtained from the Human
Research Ethics Committee at The University of Western
Australia and the Western Australian Department of Health
Confidentiality of the Health Information Committee.
Data on tea and coffee consumption 10 years previously
were collected by self-administered questionnaire. The ques-
tions were adapted from the Arizona Tea Questionnaire,31
which was shown to have high test-retest reliability (intraclass
correlation coefficients, approximately 0.7) and high relative
validity (intraclass correlation coefficient = 0.77) when
compared with 4-day food records.31 Data on frequency of
consumption were collected for hot black tea, tea with milk,
hot green tea, hot herbal tea, hot caffeinated coffee, hot
decaffeinated coffee, and iced coffee. Tea with milk and hot
caffeinated coffee were both classified into 4 categories: none,
less than 1 cup/day, 1 cup/day, and 2 or more cups/day. Black
tea was classified into 3 categories (none, less than 1 cup/day,
and 1 or more cups/day), while green tea, herbal tea,
decaffeinated coffee, and iced coffee were all categorized as
none, less than 1 cup/month, less than 1 cup/week, and 1 or
more cups/week.
Data on food intake (including milk) 10 years previously
were collected using a validated 74-item food frequency
questionnaire developed by the Cancer Council of Victoria,32
which was found to be as reliable as other questionnaires
designed to measure recent dietary intake.33 Frequency of
consumption data were collected for total milk intake
(including flavored milk and milk added to tea and coffee).
Total milk intake was categorized as less than 1 cup/day,
1 cup/day, and 2 or more cups/day. Data from the food
frequency questionnaire were used by the Cancer Council of
Victoria to calculate daily intake of foods, specific food
nutrients, and total energy, based on Australian Food
Composition Tables.34
Participants in the WABOHS were also asked about
demographic information, smoking, physical activity,
medication use, and vitamin supplement use.
Statistical analysis
We excluded from the analysis all participants with missing
dietary data (n = 3), inconsistent information on their food
frequency questionnaire regarding fruit or vegetable intake
(n = 18), no classification of cancer site (n = 6), and extreme
energy intakes (n = 76). Extreme energy intake was defined
as less than 500 kcal/day or greater than 3500 kcal/day for
women, and less than 800 kcal/day or greater than 4000 kcal/
day for men.35 A further 34 participants were dropped because
of missing values for the potential confounders physical
activity (n = 10), diabetes (n = 4), socioeconomic status
(n = 14), and country of birth (n = 6). This left 948 controls
(556 men, 392 women) and 854 cases (281 with proximal
colon cancer [152 men, 129 women], 260 with distal colon
cancer [160 men, 100 women], and 313 with rectal cancer
[213 men, 100 women]) available for this analysis.
Logistic regression was used to assess the associations
of tea, coffee and milk consumption with CRC risk, and
multinomial logistic regression was used to determine if the
associations differed for cancers of the proximal colon, distal
colon, and rectum. Because the controls were frequency-
matched to the cases by age and sex, these variables were
included in all models. Energy intake, multivitamin use,
alcohol consumption, physical activity, body mass index at
age 40 years, smoking, diabetes, socioeconomic status, and
country of birth were considered potential confounders, based
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on previous studies.36 We also assessed the influence of fruit
consumption, vegetable consumption, meat consumption,
multivitamin use, and dietary intake of folate, fiber, sugars,
and saturated fat on the results; however, these variables had
virtually no effect on the risk estimates and were thus not
included in the final analyses. All adjustment variables were
treated as categorical variables except for energy intake,
which was continuous. All tea, coffee, and milk variables
were mutually adjusted. Tests for trend were performed by
treating dietary intakes of all food groups as continuous
variables.
The proportion of missing data was 8.7% for BMI at age 40
years (Table 1) and generally less than 1% for the other
variables. To account for this in the fully adjusted models,
missing BMI data were imputed using the multiple imputation
command, ice.37 All the exposure and outcome variables
included in the final model, as well as height, maximum
weight, and weight in the previous year, at age 20 years, and
at age 60 years, were included in the imputation procedure.
There was no significant interaction between sex and any of
the exposure variables (P > 0.1), so men and women were
combined in all analyses. Differences in the beta estimate for
each risk factor across colorectal subsites were tested using the
post-estimation commands written by Long and Freese.38 Data
were analyzed using Stata 11.1 (StataCorp, College Station,
TX, USA).
RESULTS
Cases were more likely than controls to have received
a diagnosis of diabetes, resided in areas with lower
socioeconomic status, consumed more than 30 grams of
alcohol per day, and have been overweight or obese at age 40
years (Table 1). Mean energy intake was also higher among
cases than among controls. Cases were less likely than
controls to have never smoked, to have taken multivitamins,
and to have been born in Australia or New Zealand.
The adjusted odds ratios (AORs) and 95% CIs for the
associations of each tea, coffee, and milk type consumed
10 years previously with CRC risk are summarized in
Table 2; subsite-specific results are summarized in Table 3.
Consumption of black tea with or without milk was associated
with a slight increase in CRC risk at all sites, although none
of the risk increases were statistically significant and there
was no indication of a dose-response relationship.
Participants who consumed 1 or more cups of herbal tea
a week 10 years previously had a significantly reduced risk
of distal colon cancer as compared with participants who
consumed no herbal tea (AOR, 0.37; 95% CI, 0.16–0.82;
Table 3). Herbal tea consumption was not associated with the
risks of proximal colon cancer or rectal cancer, but the effect
of herbal tea differed significantly between the proximal and
distal colon (P = 0.04). Green tea was not associated with total
or subsite-specific CRC risk (Tables 2 and 3).
Hot coffee consumption was not significantly associated
with total CRC risk (Table 2), although elevated risks were
seen for distal colon cancer (Table 3). Participants who
consumed some iced coffee, but less than 1 cup per week, had
an increased risk of distal colon cancer (AOR, 1.63; 95% CI,
1.04–2.54) and rectal cancer (AOR, 2.06; 95% CI, 1.37–3.10)
as compared with those who consumed none; however,
Table 1. Distribution of sociodemographic, lifestyle, and
dietary characteristics among cases and controls







Male (%) 61.6 58.6
Female (%) 38.4 41.4
Age (years)
Mean ± SD 65.0 ± 8.9 64.6 ± 9.4
Age group
40–49 years (%) 4.8 7.0
50–59 years (%) 24.1 21.8
60–69 years (%) 36.4 35.2
70–79 years (%) 34.7 36.0
Energy intake (kJ)
Mean ± SD 8636 ± 2772 8338 ± 2764
Range 2278–16664 2298–16714
Multivitamin use
Yes (%) 34.4 39.8
No (%) 65.6 60.2
Alcohol consumption (grams/day)
<10 (%) 48.1 51.1
10–19.9 (%) 13.3 15.6
20–29.9 (%) 12.4 11.2
≥30 (%) 26.1 22.2
Physical activity at age 19–34 years
<150min/week (%) 50.4 50.4
≥150min/week (%) 49.6 49.6
Smoking
Never (%) 39.8 45.8
Former (%) 51.1 44.6
Current (%) 9.1 9.6
Diabetes
Neither (%) 79.4 85.8
High blood sugar levels only (%) 5.6 5.2
Non-insulin dependent (%) 12.6 7.8
Insulin dependent (%) 2.3 1.3
Socioeconomic status
Quintile 1 – Lowest (%) 24.9 19.6
Quintile 2 (%) 16.4 20.6
Quintile 3 (%) 19.0 19.5
Quintile 4 (%) 21.1 20.0
Quintile 5 – Highest (%) 18.6 20.3
Country of birth
Australia/New Zealand (%) 62.2 66.9
Europe (%) 31.6 28.6
Other (%) 6.2 4.5
Body mass index at age 40 years
<25 (%) 48.4 53.4
25.0–29.9 (%) 30.9 29.3
≥30 (%) 11.8 8.6
Missing (%) 8.9 8.6
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consumption of 1 or more cups per week was only associated
with a nonsignificant increase in rectal cancer risk (AOR,
1.52; 95% CI, 0.91–2.54). Decaffeinated coffee and total milk
intake were not significantly associated with total or subsite-
specific CRC risk (Tables 2 and 3).
Except where mentioned above, none of the beta estimates
for any of the exposure variables significantly differed across
colorectal subsites.
DISCUSSION
The results of this study suggest that consumption of herbal
tea and iced coffee may be associated with the risk of cancers
arising in different parts of the colorectum. Consumption of
herbal tea was associated with a significantly decreased risk of
distal colon cancer, and consumption of iced coffee was
associated with a significantly increased risk of rectal cancer.











None 583 (358/225) 647 (381/266) 1.00
<1 cup/day 138 (83/55) 159 (98/61) 0.96 (0.73–1.28)
≥1 cup/day 133 (84/49) 142 (77/65) 1.29 (0.94–1.77)
P trend 0.196
Tea with milk
None 258 (157/101) 317 (172/145) 1.00
<1 cup/day 159 (111/47) 155 (100/55) 1.34 (0.98–1.82)
1 cup/day 191 (107/84) 201 (111/90) 1.33 (0.98–1.79)
≥2 cups/day 247 (150/97) 275 (173/102) 1.22 (0.91–1.64)
P trend 0.218
Green tea
None 739 (469/270) 811 (489/322)
<1 cup/month 51 (26/25) 59 (34/25) 0.99 (0.64–1.52)
<1 cup/week 24 (13/11) 25 (14/11) 1.15 (0.62–2.13)
≥1 cup/week 40 (17/23) 53 (19/34) 0.99 (0.62–1.58)
P trend 0.920
Herbal tea
None 720 (480/340) 769 (481/288) 1.00
<1 cup/month 46 (16/30) 54 (26/28) 1.00 (0.63–1.57)
<1 cup/week 43 (17/26) 48 (27/21) 1.01 (0.63–1.60)
≥1 cup/week 45 (12/33) 77 (22/55) 0.69 (0.45–1.05)
P trend 0.149
Hot coffee
None 71 (42/29) 101 (52/49) 1.00
<1 cup/day 273 (165/108) 312 (178/134) 1.22 (0.85–1.75)
1 cup/day 300 (182/118) 312 (184/128) 1.36 (0.95–1.96)
≥2 cups/day 210 (136/74) 223 (142/81) 1.24 (0.84–1.84)
P trend 0.295
Iced coffee
None 512 (325/187) 590 (371/219) 1.00
<1 cup/month 158 (91/67) 210 (101/109) 0.89 (0.69–1.15)
<1 cup/week 123 (69/54) 88 (48/40) 1.64 (1.20–2.24)
≥1 cup/week 61 (40/21) 60 (36/24) 1.19 (0.80–1.76)
P trend 0.035
Decaffeinated coffee
None 721 (459/262) 786 (468/318) 1.00
<1 cup/month 39 (19/20) 65 (36/29) 0.68 (0.44–1.05)
<1 cup/week 28 (16/12) 25 (15/10) 1.28 (0.72–2.27)
≥1 cup/week 66 (31/35) 72 (37/35) 1.14 (0.79–1.65)
P trend 0.536
Total milk intake
<1 cup/day 436 (282/154) 501 (302/199) 1.00
1 cup/day 335 (189/146) 364 (202/162) 1.03 (0.83–1.27)
≥2 cups/day 83 (54/29) 83 (52/31) 1.02 (0.71–1.46)
P trend 0.850
AOR = Adjusted Odds Ratio.
aAdjusted for age group, sex, energy intake from food, alcohol intake, smoking status, use of multivitamins, diabetes, physical activity during the
age period 19–34 years, body mass index at age 40 years, socioeconomic status, and country of birth.
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However, neither herbal tea consumption nor iced coffee
consumption was associated with the risk of proximal colon
cancer. Hot caffeinated coffee was associated with a possible
increased risk of distal colon cancer. Black tea (with or
without milk), green tea, decaffeinated coffee, and milk were
not significantly associated with CRC risk at any subsite.
The results of this study suggest a possible inverse
association between herbal tea and distal colon cancer risk.
However, this finding is difficult to interpret, as herbal tea is a
broad term used to describe many different hot teas, such as
peppermint, chamomile, rooibos, and ginger teas. Information
on the type of herbal tea consumed was not collected in this
study. One possibility for this finding is that people who drink
herbal tea may be more health conscious than those do not;
however, adjusting for lifestyle factors such as physical
activity, smoking, and alcohol intake did not affect the inverse
Table 3. Associations of tea, coffee, and milk consumption with risks of proximal and distal colon cancer and rectal cancer in
the Western Australian Bowel Health Study, 2005–2007
Consumption Variable
(10 years previously)
Proximal colon (n = 281) Distal colon (n = 260) Rectum (n = 313)
n AOR (95% CI)a n AOR (95% CI)a n AOR (95% CI)a
Black tea
None 191 1.00 177 1.00 215 1.00
<1 cup/day 43 0.91 (0.60–1.37) 46 1.09 (0.72–1.66) 49 0.91 (0.61–1.35)
≥1 cup/day 47 1.24 (0.79–1.93) 37 1.33 (0.82–2.15) 49 1.31 (0.85–2.04)
P trend 0.486 0.254 0.364
Tea with milk
None 90 1.00 77 1.00 91 1.00
<1 cup/day 45 1.15 (0.73–1.80) 53 1.48 (0.94–2.33) 60 1.38 (0.90–2.12)
1 cup/day 62 1.15 (0.75–1.76) 61 1.49 (0.95–2.32) 68 1.36 (0.90–2.07)
≥2 cups/day 84 1.12 (0.74–1.70) 69 1.28 (0.82–2.01) 94 1.30 (0.86–1.95)
P trend 0.611 0.298 0.250
Green tea
None 240 1.00 226 1.00 273 1.00
<1 cup/month 21 1.36 (0.76–2.41) 14 0.75 (0.38–1.46) 16 0.91 (0.48–1.71)
<1 cup/week 4 0.61 (0.20–1.83) 9 1.31 (0.55–3.10) 11 1.49 (0.67–3.32)
≥1 cup/week 16 0.95 (0.50–1.78) 11 0.97 (0.47–2.03) 13 1.05 (0.53–2.10)
P trend 0.837 0.975 0.670
Herbal tea
None 230 1.00 222 1.00 268 1.00
<1 cup/month 15 0.94 (0.49–1.82) 16 1.17 (0.61–2.27) 15 0.90 (0.46–1.75)
<1 cup/week 15 1.11 (0.58–2.13) 14 0.97 (0.49–1.90) 14 0.94 (0.48–1.84)
≥1 cup/week 21 0.95 (0.54–1.66)b 8 0.37 (0.16–0.82)b 16 0.73 (0.39–1.35)
P trend 0.966 0.044 0.329
Hot coffee
None 27 1.00 16 1.00 28 1.00
<1 cup/day 93 1.11 (0.67–1.83) 80 1.55 (0.85–2.84) 100 1.11 (0.67–1.84)
1 cup/day 93 1.11 (0.67–1.85) 95 1.91 (1.05–3.48) 112 1.28 (0.78–2.11)
≥2 cups/day 68 1.11 (0.64–1.91) 69 1.78 (0.94–3.36) 73 1.05 (0.61–1.81)
P trend 0.780 0.085 0.790
Iced coffee
None 168 1.00 164 1.00 180 1.00
<1 cup/month 62 1.01 (0.71–1.44) 43 0.74 (0.50–1.11) 53 0.89 (0.61–1.28)
<1 cup/week 32 1.23 (0.78–1.95) 39 1.63 (1.04–2.54) 52 2.06 (1.37–3.10)
≥1 cup/week 19 1.11 (0.63–1.96) 14 0.86 (0.46–1.63) 28 1.52 (0.91–2.54)
P trend 0.474 0.551 0.004
Decaffeinated coffee
None 234 1.00 223 1.00 264 1.00
<1 cup/month 10 0.51 (0.25–1.03) 15 0.84 (0.45–1.57) 14 0.72 (0.39–1.36)
<1 cup/week 11 1.51 (0.70–3.22) 4 0.58 (0.19–1.75) 13 1.69 (0.82–3.51)
≥1 cup/week 26 1.19 (0.73–1.94) 18 1.16 (0.66–2.03) 22 1.06 (0.63–1.80)
P trend 0.515 0.978 0.604
Total milk intake
<1 cup/day 134 1.00 143 1.00 159 1.00
1 cup/day 122 1.20 (0.88–1.62) 96 0.91 (0.66–1.25) 117 0.99 (0.74–1.34)
≥2 cups/day 25 0.96 (0.57–1.62) 21 0.85 (0.49–1.49) 37 1.24 (0.77–1.98)
P trend 0.639 0.474 0.522
AOR = Adjusted Odds Ratio.
aAdjusted for age group, sex, energy intake from food, alcohol intake, smoking status, use of multivitamins, diabetes, physical activity during the
age period 19–34 years, body mass index at age 40 years, socioeconomic status, and country of birth.
bP-value for difference between proximal colon and distal colon is <0.05.
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association between herbal tea and the risk of distal colon
cancer. It is also possible that the association was a chance
finding. Two previous case-control studies found an inverse
association between herbal tea and breast cancer risk,15,16
which suggests that the association between specific herbal
teas and cancer risk is an area that warrants further research.
Consumption of iced coffee was significantly associated
with increased risk of rectal cancer in this study population. In
Australia, iced coffee is typically pre-made with sugar and
milk. However, hot coffee, decaffeinated coffee, and milk
were not associated with rectal cancer risk in this study,
which suggests the positive association with iced coffee is a
chance association. Another possibility is that the sugar in
iced coffee increases rectal cancer risk, as iced coffee contains
substantially more sugar than does hot coffee, and there is
suggestive evidence that consumption of foods containing
high amounts of sugar is associated with increased CRC risk.5
Hot coffee was associated with increased CRC risk in this
study, although in subsite-specific analyses the increased risk
was seen only for distal colon cancer. Other studies have
reported elevated risk estimates for the association between
coffee and CRC39–41; however, this finding is inconsistent
with much of the previous literature. A meta-analysis of case-
control studies found a modest inverse association between
coffee consumption and CRC, although a high degree of
heterogeneity was observed in the included studies.42 One
possible reason for our somewhat inconsistent finding is that
most case-control studies of coffee and CRC risk have been
conducted in Europe, where the methods used to prepare
and brew coffee may differ from those used in other parts of
the world.43 A meta-analysis of cohort studies found no
significant association between coffee consumption and CRC
risk,23 suggesting that coffee consumption does not influence
the development of CRC and that the increased risk found in
this study may be a chance finding. Of the previous studies
that examined the effect of coffee on subsite-specific CRC
risk,44–48 only 1 found that coffee had a differential effect on
the risks of proximal colon and distal colon cancers,44 and
none found a significant association between coffee and rectal
cancer risk.44–47 Given the results of previous research, it is
likely that the possible subsite differences observed in this
study are due to chance. Decaffeinated coffee intake was not
associated with CRC risk in this study.
Black tea (with or without milk), green tea, and milk were
not significantly associated with CRC risk, regardless of
subsite. The lack of a significant association between black tea
and CRC risk in this study is consistent with previous
research,49 as is our finding that the effect of black tea on
colon cancer does not differ by subsite (proximal vs distal
colon).44,46,48,50 Our finding that green tea was not associated
with CRC risk is consistent with cohort studies of this issue,
although some case-control studies found a significant risk
reduction.49 Although previous studies found a modest
reduction in CRC risk with milk intake (10% decreased risk
per 200 grams consumed per day),5,51 we found no association
between milk intake and CRC risk in this study, possibly
because the small number of participants for each CRC subsite
in this study resulted in insufficient statistical power to detect
an association of this magnitude.
The genetic, and morphologic differences between
proximal and distal colon cancers may result in differential
susceptibility to environmental risk factors. However, while
there are no obvious mechanistic reasons why consumption of
the presently investigated beverages should have differential
effects on the risk of cancers arising in different parts of the
colon, three possible mechanisms are polyphenols, N-nitroso
compounds, and bile acids. A recent study found that
polyphenol intake was differentially associated with the
risks of proximal and distal colon cancer.52 Polyphenols
in teas and coffee may reduce cancer risk by blocking
endogenous formation of N-nitroso compounds,53 and
research suggests that markers of N-nitroso compounds
differ by colorectal subsite.54 Consumption of caffeinated
beverages may reduce CRC risk by reducing secretion of bile
acids,43 and research indicates that metabolism of bile acids
may differ in the proximal and distal colon.55 Further
epidemiologic research is needed to determine whether the
beverages investigated in this study have different effects on
the risk of cancers arising in different parts of the colorectum,
and further mechanistic evidence is needed to understand why
this may be the case.
This study had several limitations. The prevalence of the
highest level of several of the exposures was less than 10%,
and the small number of participants in some categories of
the subsite-specific analyses resulted in insufficient power to
detect small increases or decreases in risk associated with
some of the exposures. For example, a post-hoc power
calculation for herbal tea indicated that we had 83% power
(with 8.1% exposure among controls and 3 controls per case)
to detect the observed odds ratio of 0.37 for distal colon
cancer but only 20% power to detect the odds ratio of 0.73
associated with rectal cancer. Also, the low proportion of
participants who regularly consumed (ie, >1 cup per week)
green tea, herbal tea, or decaffeinated coffee meant that we
were unable to investigate whether higher consumption of
these beverages was associated with overall or subsite-specific
CRC risk in this study population. Research in populations
with higher consumption of these beverages is needed in
order to improve understanding of their effects on CRC risk.
The food frequency questionnaire used in this study asked
about dietary intake 10 years previously, which increases the
chance of recall bias. However, we do not expect that recall
would be differential between cases and controls. Asking
participants to recall their dietary intake 10 years before
may also have increased the likelihood of exposure
misclassification, which may have biased the risk estimates
towards the null. However, the food frequency questionnaire
used in this study was found to be as reliable as other
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questionnaires designed to measure recent dietary intake.33
It is also possible that 10 years may not have been the
appropriate latency period. Finally, while response fractions
of 59.5% and 46.5% for cases and controls, respectively,
increase the potential for selection bias, there is no reason
to believe that tea, coffee, or milk consumption would have
necessarily influenced participation in this study.
One strength of this study was the use of pathology reports
for accurate determination of site of cancer origin in the large
bowel. A further strength of this study was the measurement
of tea and coffee, which included the type consumed,
frequency of consumption, and amount of consumption.
However, the exposure assessment used in this study may not
accurately reflect tea flavonoid consumption or intakes of
Maillard reaction products, cafestol, or kahweol in coffee, that
is, the antioxidants and potential anticarcinogens that reach the
colon and rectum. It has been suggested that research in this
area should collect information on preparation (eg, hot, iced,
brew time, brew strength/concentration), volume consumed
per serving, and tea or coffee type (eg, green, oolong, black,
caffeinated/decaffeinated, filtered/unfiltered), as these factors
influence antioxidant bioavailability in the colon and rectum.8
In conclusion, this study found that consumption of black
tea (with or without milk), green tea, decaffeinated coffee, and
milk were not significantly associated with CRC risk. Hot
coffee was associated with a possible increased risk of distal
colon cancer; however, this finding is inconsistent with much
of the previous literature. An association between iced coffee
and increased risk of rectal cancer was internally inconsistent
and may be a chance finding. Herbal tea consumption was
associated with a significantly decreased risk of distal colon
cancer, and this relationship may warrant further investigation.
ACKNOWLEDGMENTS
This study was financially supported by the Australian
National Health and Medical Research Council (Project
Grant #353568 and Fellowship #37614900 to LF) and the
Dutch Cancer Society (PD). The authors thank Barry
Iacopetta, Kieran McCaul, David Crawford, Tim Threlfall,
Cassandra Clayforth, Jenny Landrigan, Jen Girschik, Clare
Tran, and Beatriz Cuesta-Briand for their contributions to the
Western Australian Bowel Health Study.
Conflicts of interest: None declared.
REFERENCES
1. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S,
Parr CL, Woodward M. The impact of dietary and lifestyle risk
factors on risk of colorectal cancer: a quantitative overview of
the epidemiological evidence. Int J Cancer. 2009;125(1):171–80.
2. Johnson IT, Lund EK. Nutrition, obesity and colorectal cancer.
Aliment Pharmacol Ther. 2007;26(2):161–81.
3. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis
RC. Diet, nutrition and the prevention of cancer. Public Health
Nutr. 2004;7(1A):187–200.
4. Potter JD. Nutrition and colorectal cancer. Cancer Causes
Control. 1996;7(1):127–46.
5. World Cancer Research Fund, American Institute for Cancer
Research. WCRF/AICR systematic literature review continuous
update project report: the associations between food, nutrition
and physical activity and the risk of colorectal cancer.
Washington DC: AICR; 2011.
6. Trevisanato SI, Kim YI. Tea and health. Nutr Rev. 2000;58(1):
1–10.
7. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by
tea. Annu Rev Pharmacol Toxicol. 2002;42:25–54.
8. Hakim IA, Weisgerber UM, Harris RB, Balentine D, van-Mierlo
CA, Paetau-Robinson I. Preparation, composition and
consumption patterns of tea-based beverages in Arizona. Nutr
Res. 2000;20(12):1715–24.
9. Lambert JD, Lee MJ, Diamond L, Ju J, Hong J, Bose M, et al.
Dose-dependent levels of epigallocatechin-3-gallate in human
colon cancer cells and mouse plasma and tissues. Drug Metab
Dispos. 2006;34(1):8–11.
10. Chung FL, Schwartz J, Herzog CR, Yang YM. Tea and cancer
prevention: studies in animals and humans. J Nutr. 2003;
133(10):3268S–74S.
11. Tavani A, La Vecchia C. Coffee, decaffeinated coffee, tea and
cancer of the colon and rectum: a review of epidemiological
studies, 1990–2003. Cancer Causes Control. 2004;15(8):743–57.
12. Arab L, Il’yasova D. The epidemiology of tea consumption and
colorectal cancer incidence. J Nutr. 2003;133(10):3310S–8S.
13. Ahmed FE. Effect of diet, life style, and other environmental/
chemopreventive factors on colorectal cancer development,
and assessment of the risks. J Environ Sci Health C Environ
Carcinog Ecotoxicol Rev. 2004;22(2):91–147.
14. Atoui AK, Mansouri A, Boskou G, Kefalas P. Tea and herbal
infusions: Their antioxidant activity and phenolic profile. Food
Chem. 2005;89(1):27–36.
15. Hirvonen T, Mennen LI, de Bree A, Castetbon K, Galan P,
Bertrais S, et al. Consumption of antioxidant-rich beverages and
risk for breast cancer in French women. Ann Epidemiol. 2006;
16:503–8.
16. Torres-Sánchez L, López-Carrillo L, López-Cervantes M,
Rueda-Neria C, Wolff MS. Food sources of phytoestrogens
and breast cancer risk in Mexican women. Nutr Cancer. 2000;
37(2):134–9.
17. Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee
drinking influences plasma antioxidant capacity in humans.
J Agric Food Chem. 2002;50(21):6211–6.
18. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW,
Schilter B. Cafestol and kahweol, two coffee specific diterpenes
with anticarcinogenic activity. Food Chem Toxicol. 2002;40(8):
1155–63.
19. Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik
KR, et al. Potential chemoprotective effects of the coffee
components kahweol and cafestol palmitates via modification
of hepatic N-acetyltransferase and glutathione S-transferase
activities. Environ Mol Mutagen. 2004;44(4):265–76.
20. Nkondjock A. Coffee consumption and the risk of cancer: An
overview. Cancer Lett. 2009;277(2):121–5.
Tea, Coffee, and Milk Consumption and Colorectal Cancer Risk152
J Epidemiol 2014;24(2):146-153
21. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB.
Contribution of caffeine to the homocysteine-raising effect of
coffee: a randomized controlled trial in humans. Am J Clin Nutr.
2002;76(6):1244–8.
22. Daglia M, Papetti A, Gregotti C, Bertè F, Gazzani G. In vitro
antioxidant and ex vivo protective activities of green and roasted
coffee. J Agric Food Chem. 2000;48(5):1449–54.
23. Je Y, Liu W, Giovannucci E. Coffee consumption and risk of
colorectal cancer: A systematic review and meta-analysis of
prospective cohort studies. Int J Cancer. 2009;124(7):1662–8.
24. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by
calcium, vitamin D and folate: molecular mechanisms. Nat Rev
Cancer. 2003;3(8):601–14.
25. McMichael AJ, Potter JD. Host factors in carcinogenesis: certain
bile-acid metabolic profiles that selectively increase the risk of
proximal colon cancer. J Natl Cancer Inst. 1985;75(2):185–91.
26. Iacopetta B. Are there two sides to colorectal cancer? Int J
Cancer. 2002;101(5):403–8.
27. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm
shift and clinical implications. J Surg Oncol. 2004;88(4):261–6.
28. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett
WC, et al. Comparison of risk factors for colon and rectal cancer.
Int J Cancer. 2004;108(3):433–42.
29. Annema N, Heyworth JS, McNaughton SA, Iacopetta B, Fritschi
L. Fruit and vegetable consumption and the risk of proximal
colon, distal colon, and rectal cancers in a case-control study in
Western Australia. J Am Diet Assoc. 2011;111(10):1479–90.
30. van Lee L, Heyworth J, McNaughton S, Iacopetta B, Clayforth
C, Fritschi L. Selected dietary micronutrients and the risk of
right- and left-sided colorectal cancers: a case-control study in
Western Australia. Ann Epidemiol. 2011;21(3):170–7.
31. Hakim IA, Hartz V, Harris RB, Balentine D, Weisgerber UM,
Graver E, et al. Reproducibility and relative validity of a
questionnaire to assess intake of black tea polyphenols in
epidemiological studies. Cancer Epidemiol Biomarkers Prev.
2001;10:667–78.
32. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G. The Anti
Cancer Council of Victoria FFQ: relative validity of nutrient
intakes compared with weighed food records in young to middle-
aged women in a study of iron supplementation. Aust N Z J
Public Health. 2000;24(6):576–83.
33. Ambrosini GL, van Roosbroeck SA, Mackerras D, Fritschi L, de
Klerk NH, Musk AW. The reliability of ten-year dietary recall:
implications for cancer research. J Nutr. 2003;133(8):2663–8.
34. National Food Authority. NUTTAB95. Canberra, Australia:
Commonwealth Government of Australia; 1995.
35. Willett WC. Nutritional epidemiology. 2 ed. New York: Oxford
University Press US; 1998.
36. Temple NJ, Gladwin KK. Fruit, vegetables and the prevention of
cancer: research challenges. Nutrition. 2003;19:467–70.
37. Royston P. Multiple imputation of missing values: update of
ICE. Stata J. 2005;5(4):527–36.
38. Long J, Freese J. Regression models for categorical outcomes
using Stata. College Station: Stata Press; 2005.
39. Slattery ML, West DW, Robison LM, French TK, Ford MH,
Schuman KL, et al. Tobacco, alcohol, coffee, and caffeine as risk
factors for colon cancer in a low-risk population. Epidemiology.
1990;1(2):141–5.
40. Boutron-Ruault MC, Senesse P, Faivre J, Chatelain N, Belghiti
C, Méance S. Foods as risk factors for colorectal cancer: a case-
control study in Burgundy (France). Eur J Cancer Prev.
1999;8(3):229–35.
41. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol,
physical activity and other risk factors for colorectal cancer: a
prospective study. Br J Cancer. 1987;55(6):687–94.
42. Galeone C, Turati F, La Vecchia C, Tavani A. Coffee
consumption and risk of colorectal cancer: a meta-analysis
of case-control studies. Cancer Causes Control. 2010;21(11):
1949–59.
43. Michels KB, Willett WC, Fuchs CS, Giovannucci E. Coffee, tea,
and caffeine consumption and incidence of colon and rectal
cancer. J Natl Cancer Inst. 2005;97(4):282–92.
44. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW,
Hollenbeck AR, et al. Caffeinated and decaffeinated coffee and
tea intakes and risk of colorectal cancer in a large prospective
study. Am J Clin Nutr. 2012;96(2):374–81.
45. Terry P, Bergkvist L, Holmberg L, Wolk A. Coffee consumption
and risk of colorectal cancer in a population based prospective
cohort of Swedish women. Gut. 2001;49(1):87–90.
46. Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M,
Taylor PR, et al. Tea and coffee consumption and risk of colon
and rectal cancer in middle-aged Finnish men. Nutr Cancer.
1998;31(1):41–8.
47. Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N,
Matsuda-Ohmori K, et al. Coffee consumption and the risk of
colorectal cancer: A prospective cohort study in Japan. Int J
Cancer. 2007;120(7):1542–7.
48. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring
JE, Flood A, et al. Risk of colon cancer and coffee, tea, and
sugar-sweetened soft drink intake: pooled analysis of prospective
cohort studies. J Natl Cancer Inst. 2010;102(11):771–83.
49. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and
colorectal cancer risk: a meta-analysis of epidemiologic studies.
Carcinogenesis. 2006;27(7):1301–9.
50. Cerhan JR, Putnam SD, Bianchi GD, Parker AS, Lynch CF,
Cantor KP. Tea consumption and risk of cancer of the colon and
rectum. Nutr Cancer. 2001;41(1–2):33–40.
51. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman
E, et al. Dairy products and colorectal cancer risk: a systematic
review and meta-analysis of cohort studies. Ann Oncol. 2012;
23(1):37–45.
52. Wang ZJ, Ohnaka K, Morita M, Toyomura K, Kono S, Ueki T,
et al. Dietary polyphenols and colorectal cancer risk: the
Fukuoka colorectal cancer study. World J Gastroenterol. 2013;
19(17):2683–90.
53. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst.
1993;85(13):1038–49.
54. Hjartåker A, Aagnes B, Robsahm TE, Langseth H, Bray F,
Larsen IK. Subsite-specific dietary risk factors for colorectal
cancer: a review of cohort studies. J Oncol. 2013;2013:703854.
55. Thomas LA, Veysey MJ, French G, Hylemon PB, Murphy GM,
Dowling RH. Bile acid metabolism by fresh human colonic
contents: a comparison of caecal versus faecal samples. Gut.
2001;49(6):835–42.
Green CJ, et al. 153
J Epidemiol 2014;24(2):146-153
